According to the current analysis of Reports and Data, the ELISpot Assay Market was valued at USD 123.5 million in 2018 and is expected to reach USD 408.8 million by the year 2026, at a CAGR of 15.9%. ELISpot, also known as Enzyme-linked immune absorbent spot and Fluorospot, are assay methods used to detect cytokine secretion in samples, including blood plasma, serum, tissues, and others. The technique is antibody-based, wherein the microplates used in the assay are covered by specific antibodies that detect significant proteins from the sample. The ELISpot and Fluorospot are used on a regular basis in various research institutes for cytokine detection and analysis secreted by single cells.

The rise in the research and development in the vaccines sector is expected to drive the market majorly. Rising prevalence of infectious diseases that can be detected using ELISpot Assay methods is also a driving factor for the market. For instance, according to the estimates given by the World Health Organization (WHO), around 30 new diseases have emerged in the last 20 years, and now these diseases threaten the health of millions of people in the world. Moreover, the epidemics of infectious diseases worldwide affect around 3 to 5 million people annually and cause severe illness. Various companies have invested in the R&D sector to improve the assay techniques and to gain reliable results. Moreover, the rising cases of chronic disorders and increasing awareness about the diagnosis of chronic diseases are expected to propel the demand extensively. There is a significant increase in healthcare expenditure in developing countries, which could contribute to the growth of the industry.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.reportsanddata.com/download-free-sample/2697

Further key findings from the report suggest

  • Different companies continue to be leaders since the introduction of ELISpot Assay techniques. For instance, Oxford Immunotech is the leading company in the market. The company has established itself across the globe and used various strategies to improve its presence in the market
  • The analyzers segment is widely driven due to the company called Cellular Technology Limited (CTL), which is the first company to introduce analyzers in ELISpot in the market. It has been a leading player in the industry since then.
  • Many technological advancements have led the market toward growth. For instance, in 2018, Mabtech launched an analyzer called IRIS analyzer, which is a 4-color fluorospot and ELISpot reader.
  • Also, in 2018, in the assay kits sector, Mabtech introduced a human IL3 ELISpot kit. Such advancements continue the growth of the company in the market

Competitive Outlook of the Global ELISpot Assay Market

The globla ELISpot Assay market study focuses on the revenue growth trajectories of the leading companies in this market. This section of the report throws light on the highly competitive landscape of the ELISpot Assay market, pointing out the major players. The report further discusses the strategic initiatives undertaken by each of these market players, including mergers & acquisitions, collaborations, joint ventures, new product launches, new business deals, and technological innovations.

Top Companies Profiled in the Report:

Oxford Immunotec, Cellular Technologies, Mabtech, Becton, Dickinson and Company, Abcam, Bio-Techne, U-Cytech Biosciences, Lophius Biosciences GmbH, and Biotech Investissement Group.

Inquiry Before Buying @ https://www.reportsanddata.com/inquiry-before-buying/2697

The report is inclusive of product type outlook, application spectrum, end-use outlook, technology landscape, regional market analysis, and competitive overview.

ELISpot Assay Market Segmentation:

By Product (Revenue in Million USD; 2016–2026)

  • Assay Kits
    • B cell assay
    • T cell assay
  • Ancillary products
  • Analyzers

By Application (Revenue in Million USD; 2016–2026)

  • Cancer
  • Diagnostics
    • Transplants
    • Infectious diseases
  • Vaccines
  • Clinical trials
  • Others

By End Use (Revenue in Million USD; 2016–2026)

  • Research Institutes
  • Diagnostic Centers
  • Hospital and clinics
  • Ambulatory surgical centers
  • Others

Geographic Segment Covered in the Report:

The ELISpot Assay report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country, and sub-region during the estimated period.

  • North America (USA and Canada)
  • Europe (UK, Germany, France and the rest of Europe)
  • Asia Pacific (China, Japan, India, and the rest of the Asia Pacific region)
  • Latin America (Brazil, Mexico, and the rest of Latin America)
  • Middle East and Africa (GCC and rest of the Middle East and Africa)

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/2697

Thank you for reading our report. Customization of this report is available as per the client’s requirements. Please connect with us to know more about the report and our team will ensure you get the report tailored according to your needs.

Get Explore Latest Research Report by Reports and Data:

Infrared Imaging Market @ https://www.biospace.com/article/increased-use-for-security-and-surveillance-in-healthcare-industry-is-expected-to-drive-infrared-imaging-market-revenue-growth-in-near-future-reports-and-data/

Zotepine Market @ https://www.biospace.com/article/zotepine-market-analysis-statistics-revenue-demand-and-trend-analysis-research-report-by-2028/

Hematology Instrument Market @ https://www.biospace.com/article/hematology-instrument-market-growth-global-survey-analysis-share-company-profiles-and-forecast-by-2028/

Urinary Stone Treatment Device Market @ https://www.biospace.com/article/urinary-stone-treatment-device-market-trends-revenue-key-players-growth-share-and-forecast-till-2028/

Gynecological Devices Market @ https://www.biospace.com/article/gynecological-devices-market-trends-revenue-key-players-growth-share-and-forecast-till-2028/

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com